AG Barr beats profit forecast, expects stronger revenue growth in year ahead

Adjusted pretax profit £65.8m (up 12.5%), narrowly ahead of the £65.4m forecast; revenue rose 4% to £437.3m and adjusted EPS was 44.24p, with adjusted ROCE 20.4% and operating margin 14.8%. Management is reshaping the portfolio toward energy and wellness (sold Strathmore, acquired Frobishers) and guides to low double-digit revenue growth in FY2026/27, with long-term targets of ≥4% annual revenue growth, 14–16% operating margin and 19–21% ROCE. The company said the Middle East conflict has only limited direct impact (energy cost pressure) and no direct revenue exposure.

Analysis

The company’s pivot toward higher‑ASP energy/wellness SKUs creates a margin and distribution arbitrage that incumbents with legacy cola portfolios will struggle to match quickly. Expect margin expansion to come via three levers: mix shift to higher gross margin SKUs, reduced promotional intensity as brand equity for niche SKUs builds, and slotting gains in convenience channels where energy drinks command premium pricing. Downstream, co‑packers and can suppliers should see order volatility as lines are rebalanced toward smaller‑format, high‑frequency SKUs, and freight patterns shift from bottled water runs to chilled convenience replenishment.

Key near‑term risks are commodity and energy cost pass‑through, shelf‑space churn with major retailers, and the cadence of successful NPD rollouts; any one of these can knock the timeline for achieving premium margins by 6–18 months. Regulatory moves (e.g., sugar levies or labeling rules) are low‑probability but high‑impact tail risks over a 1–3 year horizon, and an adverse campaign could force reformulation costs and temporary volume declines. Watch three forward catalysts as binary checks: sustained repeat purchase rates from trade data, incremental retail listings in national convenience chains, and the next quarter’s gross margin trajectory.

Contrarian read: the market is under‑pricing optionality from disciplined M&A and sku rationalization — small tuck‑ins that raise blended margins by 200–400bps would create asymmetric upside because the base business already generates high ROCE. Execution is the real bet: if management holds marketing spend discipline while scaling distribution, upside within 12–24 months is plausibly +30–50%; conversely, aggressive marketing to buy growth or repeated price promotions would compress operating leverage and materially cut expected returns. Capitalize via concentrated, event‑linked positions rather than blunt market exposure.

Key Decisions for Investors

• Long BAG.L (2–3% portfolio weight) — buy shares on a sub‑20% drawdown from current levels; target +40% in 12–24 months, hard stop at -15% or hedge with 6–12m puts to cap downside (R/R ~ 2.5:1 assuming target hit).
• Pairs trade: long BAG.L / short CCEP.L (1:1 exposure) to isolate category/mix upside — expect relative outperformance of ~30% over 12 months if energy/wellness distribution accelerates; tighten or unwind if the spread narrows >15% in 60 days.
• Options: buy 12‑18 month BAG.L call spread (buy ATM, sell ~30% OTM) to pay for upside while capping premium — max loss = net premium, asymmetry if >30% move occurs before expiry; use for a tactical 0.5–1% position.
• Event hedge: reduce gross exposure by 50% if next two quarterly releases miss repeat purchase or gross margin signals, or add 50% if sequential gross margin improves >100bps and new national retail listings are announced (timeframe 3–6 months).